Results 51 to 60 of about 47,491 (152)

Does local vancomycin powder impregnated with autogenous bone graft and bone substitute decrease the risk of deep surgical site infection in degenerative lumbar spine fusion surgery?—An ambispective study

BMC Musculoskeletal Disorders, 2022
Background Deep surgical site infection (DSSI) is one of the most challenging complications in lumbar fusion surgery. Few investigations examined the effect of vancomycin powder mixed with autogenic bone graft (ABG) and bone substitutes on preventing ...
Po-Hsin Chou, Hsi-Hsien Lin, Yu-Cheng Yao, Ming-Chau Chang, Chien-Lin Liu, Shih-Tien Wang   +5 more
doaj   +1 more source

Vancomycin-resistantEnterococcus

Swiss Medical Weekly, 2012
The reported prevalence of vancomycin-resistant Enterococcus faecium (VRE) in Switzerland for the years 2008–2010 has been low at <5%. At the University Hospital Zurich, 17 cases of VRE were detected between 28 December 2009 and 15 February 2010. Nine cases were diagnosed clinically; eight cases were detected by rectal screening. The centre of
Thierfelder, C, Keller, P M, Kocher, C, Gaudenz, R, Hombach, M, Bloemberg, G V, Ruef, C   +6 more
openaire   +5 more sources

Vancomycin- and Strontium-Loaded Microspheres with Multifunctional Activities against Bacteria, in Angiogenesis, and in Osteogenesis for Enhancing Infected Bone Regeneration

, 2019
Biomaterials that have capacities to simultaneously induce bone regeneration and kill bacteria are in demand because bone defects face risks of severe infection in clinical therapy.
Pengfei Wei (662637), Wei Jing (535271), Binbin Guan (3979136), Zuoying Yuan (7250933), Wenxin Zhang (112161), Jianping Mao (3408392), Yiqian Huang (7250936), Xu Zhang (49484), Xiaoping Yang (460478), Qing Cai (247954), Dafu Chen (291913)   +10 more
core   +1 more source

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

BMC Infectious Diseases, 2011
Background The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections.
McGregor Jessina C, Shardell Michelle D, Johnson J Kristie, Harris Anthony D, Furuno Jon P, Schweizer Marin L, Thom Kerri A, Cosgrove Sara E, Sakoulas George, Perencevich Eli N   +9 more
doaj   +1 more source

SUMMARY [PDF]

, 2014
Vancomycin has been documented to cause various adverse cutaneous reactions. We present a case report of a man, who developed a large localized erythematous plaque in his forearm following parenteral vancomycin therapy.
Vancomycin Therapy
core  

Vancomycin-Resistant Enterococcus faecalis (VRE) control assay after 3 min exposure to 1% w/v Bioxy in neutralizer.

, 2017
Vancomycin-Resistant Enterococcus faecalis (VRE) control assay after 3 min exposure to 1% w/v Bioxy in neutralizer.
Ken Ungar (3753265), Richard Robison (69760), Dori Dagher (3753271), Fadi Dagher (3753268)   +3 more
core   +1 more source

Vancomycin Revisited - 60 years later

Frontiers in Public Health, 2014
Vancomycin is one of the older antibiotics that has been now in clinical use close to 60 years. Earlier on, vancomycin was associated with many side effects including vestibular and renal, most likely due to impurities contained .in early vancomycin lots.
Ethan eRubinstein, Yoav eKeynan
doaj   +1 more source

Tracking Vancomycin MIC Creep: A Five Year Analysis [PDF]

Methicillin resistant Staphylococcus aureus (MRSA) is a known human pathogen capable of causing community and hospital acquired infections worldwide.
Deepa Devhare, Sunita Bhatawadekar, Mahadevan Kumar, Sulochana Jadhavar, Meera Modak, Vrushali Thakar   +5 more
core   +1 more source

Appropriate use of vancomycin in a cardiac surgical unit

Journal of Cardiothoracic Surgery
Background Antibiotic resistance is a rapidly growing problem. Methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) are major worries, particularly in developing nations where cost-effectiveness is essential.
Sanaa Mekdad, Leenah Alsayed, Suzan Alkhalaif   +2 more
doaj   +1 more source

Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring

Journal of Infection in Developing Countries, 2018
Introduction: Vancomycin is the cornerstone of parenteral therapy for serious methicillin resistant Staphylococcus aureus infections. Optimal dosing of vancomycin is patient specific due to its narrow therapeutic window.
Wissam K Kabbara, Ghada El-Khoury, Nour R Chamas   +2 more
doaj   +1 more source